Latest AI and machine learning research in other cancers for healthcare professionals.
Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable success in hematologic ...
BACKGROUND: Early diagnosis of sub-centimeter lung metastases is critical for timely decision-making...
BACKGROUNDS: Reoperation is a key therapeutic strategy for recurrent or persistent papillary thyroid...
BACKGROUND: Prognostic models for hepatocellular carcinoma (HCC) may have limited accuracy. We aimed...
PURPOSE: This prospective multicenter study aimed to compare the decision-making abilities of board-...
Hematologic malignancies remain among the most challenging cancers to treat due to genetic heterogen...
BACKGROUND: Outcome prediction after Gamma Knife radiosurgery (GKRS) for vestibular schwannoma remai...
BACKGROUND: Breast cancer is the most common malignant tumor affecting women, and pathology serves a...
OBJECTIVES: Pressure injuries are common chronic wounds that require accurate staging to guide manag...
Immune checkpoint inhibitors (ICIs) benefit only a subset of patients with metastatic non-small cell...
T cell receptors (TCRs) are central to adaptive immunity, yet their vast sequence and structural div...
Although deep learning models have improved individual PET analysis, image processing, and quantific...
Reirradiation (reRT) has become an essential therapeutic option for selected patients with locoregio...
Chronic liver disease (CLD) affects millions worldwide, yet accurately staging its progression witho...
Hepatocellular carcinoma is a leading cause of cancer mortality globally. Liver transplantation is c...
PURPOSE: To develop and validate a multimodal deep learning framework that integrates clinical metad...
Macroautophagy (autophagy) enables cellular stress adaptation by degrading damaged components; ULK1,...
BACKGROUND: In contrast to three decades ago, liver resection (LR) is now an increasingly common pro...
Tumor-educated platelets (TEPs) have recently emerged as an important component of liquid biopsy, ye...
Cancers of unknown primary (CUP) refer to a highly heterogeneous group of metastatic tumors whose pr...
BACKGROUND: Clinical Tumor, Node, and Metastasis (cTNM) classification is vital for predicting treat...